ATE501635T1 - Chemische hemmstoffe des mismatch-repair - Google Patents

Chemische hemmstoffe des mismatch-repair

Info

Publication number
ATE501635T1
ATE501635T1 AT01901992T AT01901992T ATE501635T1 AT E501635 T1 ATE501635 T1 AT E501635T1 AT 01901992 T AT01901992 T AT 01901992T AT 01901992 T AT01901992 T AT 01901992T AT E501635 T1 ATE501635 T1 AT E501635T1
Authority
AT
Austria
Prior art keywords
genes
mismatch
cells
mismatch repair
repari
Prior art date
Application number
AT01901992T
Other languages
English (en)
Inventor
Nicholas Nicholaides
Luigi Grasso
Philip Sass
Original Assignee
Morphotek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphotek Inc filed Critical Morphotek Inc
Application granted granted Critical
Publication of ATE501635T1 publication Critical patent/ATE501635T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • C12N15/1024In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H3/00Processes for modifying phenotypes, e.g. symbiosis with bacteria
    • A01H3/04Processes for modifying phenotypes, e.g. symbiosis with bacteria by treatment with chemicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8209Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
    • C12N15/821Non-antibiotic resistance markers, e.g. morphogenetic, metabolic markers
    • C12N15/8212Colour markers, e.g. beta-glucoronidase [GUS], green fluorescent protein [GFP], carotenoid
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT01901992T 2001-01-15 2001-01-15 Chemische hemmstoffe des mismatch-repair ATE501635T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/000934 WO2002054856A1 (en) 2001-01-15 2001-01-15 Chemical inhibitors of mismatch repair

Publications (1)

Publication Number Publication Date
ATE501635T1 true ATE501635T1 (de) 2011-04-15

Family

ID=21742243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01901992T ATE501635T1 (de) 2001-01-15 2001-01-15 Chemische hemmstoffe des mismatch-repair

Country Status (6)

Country Link
EP (1) EP1351565B1 (de)
JP (1) JP5036119B2 (de)
AT (1) ATE501635T1 (de)
CA (1) CA2434926C (de)
DE (1) DE60144247D1 (de)
WO (1) WO2002054856A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235643B2 (en) 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
US6982169B2 (en) 2001-01-15 2006-01-03 Morphotek, Inc. Chemical inhibitors of mismatch repair
EP1417329A4 (de) * 2001-07-25 2005-05-11 Morphotek Inc Verfahren zur herstellung antibiotikaresistenter mikroben und neuer antibiotika
ATE548461T1 (de) 2002-01-18 2012-03-15 Morphotek Inc Verfahren zur erzeugung manipulierter zellen zur locus-spezifischen genregulation und analyse
ATE489474T1 (de) * 2002-07-19 2010-12-15 Morphotek Inc Verfahren zur erzeugung verbesserter antikörper produzierender zellinien mit verbesserten wachstumseigenschaften
DE60329526D1 (de) 2002-11-15 2009-11-12 Morphotek Inc Verfahren zur erzeugung einer hohen antikörperproduktion von durch in-vitro-immunisierung entstandenen hybridomen
JP2007500508A (ja) 2003-07-29 2007-01-18 モルフォテック、インク. 抗体とエフェクター機能が増強された遺伝子組み換え抗体を作成する方法
US7604994B2 (en) 2003-09-03 2009-10-20 Morphotek, Inc. Genetically altered antibody-producing cell lines with improved antibody characteristics
WO2005056599A2 (en) 2003-12-08 2005-06-23 Morphotek, Inc. Antibodies that specifically bind pms2
AU2005214331B2 (en) 2004-02-12 2011-09-15 Eisai, Inc. Monoclonal antibodies that specifically bind to folate receptor alpha
WO2006032504A2 (en) * 2004-09-22 2006-03-30 Vrije Universiteit Brussel Method for introducing genetic mutations into plant cells
EP1861425B1 (de) 2005-03-10 2012-05-16 Morphotek, Inc. Anti-mesothelin-antikörper
WO2006116451A2 (en) 2005-04-22 2006-11-02 Morphotek, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
AU2006241099B2 (en) 2005-04-22 2012-04-19 Eisai, Inc. Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
CA2682726C (en) 2007-04-05 2017-05-09 Morphotek, Inc. Methods for inhibiting the binding of endosialin to ligands
EP2376637A1 (de) * 2008-12-22 2011-10-19 Keygene N.V. Verwendung von doppelstrang-rna zur erhöhung der wirksamkeit einer zielgenänderung in pflanzenprotoplasten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191268B1 (en) * 1993-12-17 2001-02-20 Dana-Farber Cancer Institute Compositions and methods relating to DNA mismatch repair genes
US5907079A (en) * 1996-01-18 1999-05-25 Amgen Canada Inc. MSH2 disrupted mice develop lymphomas
AUPO974597A0 (en) * 1997-10-10 1997-11-06 Rhone-Poulenc Agro Methods for obtaining plant varieties
US6146894A (en) * 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms

Also Published As

Publication number Publication date
WO2002054856A1 (en) 2002-07-18
EP1351565A1 (de) 2003-10-15
CA2434926C (en) 2014-04-01
DE60144247D1 (de) 2011-04-28
CA2434926A1 (en) 2002-07-18
EP1351565A4 (de) 2005-05-25
EP1351565B1 (de) 2011-03-16
JP2005510199A (ja) 2005-04-21
JP5036119B2 (ja) 2012-09-26

Similar Documents

Publication Publication Date Title
DE60144247D1 (de) Chemische hemmstoffe des mismatch-repair
CA2240609A1 (en) A method for generating hypermutable organisms
CY1112409T1 (el) Μοναδα και διεργασια για διεξαγωγη ζυμωσης υψηλης κυτταρικης πυκνοτητας
IL170221A (en) Progenitor cells from wharton's jelly of human umbilical cord and methods of obtaining and utilizing same
Cervantes et al. Embryonic stem cells and somatic cells differ in mutation frequency and type
Pellino et al. Asexual genome evolution in the apomictic R anunculus auricomus complex: examining the effects of hybridization and mutation accumulation
WO2004024871A3 (en) Antibodies and methods for generating genetically altered antibodies with high affinity
CY1118167T1 (el) Πρωτογενη και εγγυς ηπατικα βλαστοκυτταρα
Massicotte et al. General‐purpose genotype or how epigenetics extend the flexibility of a genotype
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
Lafon‐Placette et al. Methylome of DN ase I sensitive chromatin in P opulus trichocarpa shoot apical meristematic cells: a simplified approach revealing characteristics of gene‐body DNA methylation in open chromatin state
ATE420188T1 (de) Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren
WO2004063362A3 (en) Cell cycle progression proteins
ATE399871T1 (de) Methode zur herstellung hypermutabler pflanzen
ATE193729T1 (de) Geminivirus-basiertes-genexpressionsystem
MX2025007036A (es) Metodos y composiciones para generar alelos dominantes usando edicion del genoma
DE60329747D1 (de) Vektoren mit beiden isoformen von beta-hexosaminidase
IL146296A0 (en) Cell reprogramming
Krueger‐Hadfield et al. Using RAD‐seq to develop sex‐linked markers in a haplodiplontic alga
DE69935907D1 (de) Hocheffizienzverfahren und zusammensetzungen zum integrieren von exogener dna in genomische sperma-dna
MX2025001546A (es) Composiciones y metodos de tratamiento de precision de cancer
DE50012581D1 (de) Vorrichtung zum züchten und/oder behandeln von zellen
ATE499440T1 (de) Gen-targeting mit replizierenden dna-molekülen
Levins et al. Evolution of sexual systems and regressive evolution in Riccia
ATE240033T1 (de) Mit thioredoxin transformierte pflanzen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties